ID
21387
Description
NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: ABC-Containing Product Compliance Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV
Mots-clés
Versions (1)
- 19/04/2017 19/04/2017 -
Téléchargé le
19 avril 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Genetic Screening For HLA-B*5701 in Patients with HIV ABC-Containing Product Compliance NCT00340080
Genetic Screening For HLA-B*5701 ABC-Containing Product Compliance NCT00340080
Similar models
Genetic Screening For HLA-B*5701 ABC-Containing Product Compliance NCT00340080
C0013227 (UMLS CUI-2)
C0663655 (UMLS CUI-3)
C0947323 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
C0332156 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
C0947323 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
C0332156 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
C0947323 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
C0332156 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])